The cost of US pharmaceutical price regulation: a financial simulation model of R&D decisions

Article Abstract:

The impacts of regulating price in the pharmaceutical industry on industrial research and product development are evaluated using a micro-simulation model. It was found that reducing prices in U.S. pharmaceutical companies by 40-50% will result in 30% to 60% decline in research and development activities. The effects of reforms in price policies on private companies' incentives are investigated.

Product development, Commodity & service prices, Pharmaceutical preparations, Models, Economic aspects, Pharmaceutical industry, Prices and rates, Influence, Price control, Price regulations, Company pricing policy, Report

---

Interaction between public research organizations and industry in biotechnology

Article Abstract:

The most important findings of the literature on the close interaction between public research organizations and industry in biotechnology are summarized. It is suggested that the dynamic of biotechnology is unique and can be attributed to the specific institutional arrangements characterizing the American scientific system.

Science & research, Drugs, Research, Biotechnology industry, Biotechnology industries, Comparative analysis

---

Similar abstracts:

• Abstracts: The influence of the financial revolution on the nature of firms. Organizational design: decision rights and incentive contracts
• Abstracts: The production recipes approach to modeling technological innovation: an application to learning by doing. Optimal search on a technology landscape
• Abstracts: The sufficiency of the `lens condition' for factor price equalization in the case of two factors. Quasi-specific factors: worker comparative advantage in the two-sector production model
• Abstracts: Timing, investment opportunities, managerial discretion, and the security issue decision. Culture, openness, and finance
• Abstracts: Stock- market participation, intertemporal substitution, and risk- aversion. Equity-markets liberalization as country IPO's

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.